Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Apr 7;96(8):e00177-22. doi: 10.1128/jvi.00177-22

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 American Society for Microbiology.

All Rights Reserved.

This article is made available via the PMC Open Access Subset for unrestricted noncommercial re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

PMC Copyright notice

FIG 1 — (A) Total numbers of infections with SARS-CoV-2 before, during, and after the immunization regimens were subjected to a Chi-square analysis. The numbers of infected individuals were significantly reduced (P ≤ 0.05). (B) Proportions of infections with SARS-CoV-2 before (22.77%), during (2.47%), and after the immunization (2.47%) among those who were vaccinated. The number of positive patients (n = 56) corresponds to 27.72% of the total of individuals who received at least one dose of vaccine (n = 202). Among these, 46 individuals (22.77%) had the infection before being vaccinated. In addition, five individuals (2.47%) had the disease between (after the first vaccine dose), and five individuals (2.47%) had COVID-19 after the second vaccine dose.